DUBAI, Jan 18, (Xinhua): The Abu Dhabi Stem Cells Center (ADSCC) has introduced a new approach to diabetes management using umbilical cord-derived mesenchymal stem cell (MSC) therapy, the United Arab ...

The Food and Drug Administration (FDA) approved the first mesenchymal stromal cell (MSC) therapy, RYONCIL®, indicated for steroid-refracto ...

Abu Dhabi Stem Cells Center (ADSCC) announced promising results of a revolutionary advancement in the management of diabetes, successfully performing umbilical cord-derived mesenchymal stem cell ...

Abu Dhabi Stem Cells Centre (ADSCC) announced promising results of a revolutionary advancement in the management of diabetes, successfully performing umbilical cord-derived mesenchymal stem cell ...